Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;58(2):159.
doi: 10.4103/0019-5154.108079.

Disabling pansclerotic morphea of childhood with extracutaneous manifestations

Affiliations

Disabling pansclerotic morphea of childhood with extracutaneous manifestations

Mahendra M Kura et al. Indian J Dermatol. 2013 Mar.

Abstract

Disabling pansclerotic morphea (DPM) of childhood is a rare generalized type of localized scleroderma (LS) that is known to follow an aggressive course with pansclerotic lesions leading to severe joint contractures and consequent immobility. Mortality is due to complications of the disease such as bronchopneumonia, sepsis, or gangrene. There is no specific laboratory finding. Treatment protocols are still evolving for this severe recalcitrant disorder. Extracutaneous manifestations are rarely reported in DPM. We present the case of a 7-year-old girl with DPM with severe extracutaneous manifestations in the form of gastrointestinal and vascular disease, whose disease progressed rapidly. In spite of treatment with methotrexate, corticosteroids, and PUVA therapy, she ultimately succumbed to her illness due to sepsis.

Keywords: Disabling pansclerotic morphea of childhood; extracutaneous manifestations; gangrene; juvenile localized scleroderma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Figures

Figure 1
Figure 1
Generalized sclerosis of the skin with joint contractures and crusted erosions on knee
Figure 2
Figure 2
Sclerosis and contractures of hands and feet
Figure 3
Figure 3
Before and after 3 months of methotrexate showing worsening sclerosis with increasing ectropion and lagophthalmos
Figure 4
Figure 4
Cyanosis over toes, which later turned into gangrene

References

    1. Kreuter A, Krieg T, Worm M, Wenzel J, Gambichler T, Kuhn A, et al. Diagnosis and therapy of circumscribed scleroderma. J Dtsch Dermatol Ges. 2009;7(Suppl 6):S1–12. - PubMed
    1. Diaz-Perez JL, Connolly SM, Winkelmann RK. Disabling pansclerotic morphea of children. Arch Dermatol. 1980;116:169–73. - PubMed
    1. Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52:2873–81. - PubMed
    1. Zulian F, Athreya BH, Laxer R, Nelson Am, Feitosa de Oliviera SK, Punaro MG, et al. Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (PRES). Juvenile localized scleroderma: Clinical and epidemiological features in 750 children. An international study. Rheumatology. 2006;45:614–20. - PubMed
    1. Vancheeswaran R, Black CM, David J, Hasson N, Harper J, Atherton D, et al. Childhood onset scleroderma: Is it different from adult-onset disease. Arthritis Rheum. 1996;39:1041–9. - PubMed

LinkOut - more resources